CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on revaccination data for both mRNA-1010, i ...

It seems that every time we start to relax, a new Covid-19 variant surfaces. Covid-19 fatigue is real, and many people just aren’t paying attention ...

That raises the stakes for a second area of Moderna’s research. In a partnership with Merck, it’s been using its mRNA ...

The new report found that healthy adults who received the Covid vaccine cut their risk of urgent care and emergency visits by ...

The acting CDC director cited concerns with the methodology, but the design has long been used to test vaccine effectiveness.

Investigators sought to determine the long-term effects of COVID-19 infection and vaccination in patients with solid malignancies.

A public health expert breaks down the details of the CDC delaying reporting of COVID-19 vaccine benefits, including study ...

Among adolescents and young adults, cTnI levels remain within normal ranges after mRNA-1273 vaccination, with no evidence of increased myocardial injury.

MRNA COVID-19 vaccination and cancer risk are examined in a case report and review that explores a reported temporal ...

Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a ...

CLEVELAND, Ohio — This season’s influenza vaccine may have been less effective than last season’s, because it was not well ...